Investigator Site 2

Belgrade 11000

0 studies enrolling now · 3 studies all time

What they study most

Lupus Erythematosus, Systemic, Rheumatoid Arthritis

Studies at this site

• A Phase IIb Study for ALX-0061 Monotherapy in Subjects With Rheumatoid Arthritis — Completed
• A Dose-Range Finding Study for ALX-0061 Combination Therapy in Subjects With Rheumatoid Arthritis — Completed
• A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus — Completed